Experiences of Awe Mediate Ketamine's Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression.
Biological Psychiatry Global Open Science July 1, 2024 Julia Aepfelbacher, Benjamin Panny, Rebecca B Price 13 citations
Ketamine infusion strongly induced feelings of awe in people with depression, and these awe experiences consistently predicted and mediated improvements in depression scores over 1 to 30 days, unlike general dissociative effects, which did not mediate outcomes. In a study of 116 participants with depression, 77 received a ketamine infusion and 39 received saline placebo. Awe was measured 40 minutes after infusion, and depression severity was assessed at five time points afterward. Awe scores were significantly higher in the ketamine group and statistically mediated the relationship between ketamine and depression improvement at all time points, suggesting that the awe-inspiring properties of ketamine may contribute to its antidepressant effects.